Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A physician or gastroenterologist will highly likely transition the patient from the oral formulation (Rybelsus) to a subcutaneous injectable GLP-1 agonist (such as Ozempic or Wegovy)
Discuss alternatives with healthcare provider
The differences between the two drugs, aside from each drugs intended use, is the dosing, method for increasing dosage, inactive ingredients, and prescribing information
"I truly believe that this is not going to do much for anybody," she says
The rapid growth in sales could be partly attributed to aggressive marketing strategies rather than solely the drug's efficacy or innovation
US$ 21.27
US$ 24.90
US$ 20.13
US$ 20.34
US$ 27.21
US$ 23.82
US$ 25.10
US$ 29.72
